Published in Pharma Law Weekly, September 26th, 2006
AGA is the owner of a European patent (EP 0 808 138) validated in Germany (DE 695 34 505) for intravascular occlusion devices and the method of forming or manufacturing these medical devices. The patent issued in October 2005. The action, filed in Dusseldorf, requests damages against Occlutech, DRABO, their CEOs and further requests a permanent injunction prohibiting them from manufacturing and marketing infringing "Figulla Occluder."
"Using all legal methods...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly